Home
Clinical Resources Search
PQI: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancer with MET Exon 14 Alterations

Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancer with MET Exon 14 Alterations

About this PQI

Tepotinib is an oral tyrosine kinase inhibitor (TKI) designed specifically to target mesenchymal epithelial transition exon 14 skipping alterations (METex14) in non-small cell lung cancer (NSCLC).1 This PQI will discuss safety, efficacy, strategies for dosing, and side effect management.

More About This PQI

PQI in Action Articles:

tepotinib_tepmetko_NSLC pdf 1.3MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Non-Small Cell Lung Cancer (NSCLC) Tepmetko Tepotinib

PQI

Frequently Searched

Supported by

Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancer with MET Exon 14 Alterations

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

S9 E4: Advancing Pharmacogenomics in Oncology

S9 E3: Firefighter Health & Cancer Prevention

S9 E2: Love Languages in Cancer Care

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

S8 Ep 12: Lorlatinib in Practice: 5 Years of Data, Real-World Counseling, and AE Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

S9 E4: Advancing Pharmacogenomics in Oncology

S9 E3: Firefighter Health & Cancer Prevention

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management